The Texas-India vaccine diplomacy, a collaboration for shared global health between Indian pharmaceutical company Biological E and the Texas Children’s Hospital and Baylor College of Medicine, has led to the development of a cost-efficient vaccine against COVID-19 for USD 1.50 per dose, according to a top American scientist.
Addressing the annual 2021 gala of the Indo-American Chamber of Commerce of Greater Houston (IACCGH) on Saturday, Dr Peter Hotez, Dean National School of Tropical Medicine; professor of pediatrics, molecular virology and molecular biology, at Baylor College of Medicine, said the collaboration has led to the development of the low-cost people’s vaccine in record times.